Training Programs

Clinical Pharmacology Training Network (CPTN)

BPCA legislation mandates the training of experts in pediatric pharmacology research. Since 2012, the BPCA program includes a T32 CPTN institutional research training grant program to help ensure that a diverse and highly trained workforce is available in an area that currently has a limited number of researchers. Without an increase in the pool of investigators trained in new "-omics" technologies and their application to pediatric therapeutics, integration and synergistic interaction will not be possible, and the overall goal of personalized pediatric therapeutics will not be realized. 

This collaborative network allows interdisciplinary collaboration of clinical, translational, and basic investigators who research pediatric therapeutics.

Goals of the CPTN include:

  • Provide training in pediatric clinical pharmacology
  • Stimulate interdisciplinary collaboration among clinical, translational, and basic researchers in pediatric therapeutics
  • Enable the development of a pediatric pharmacology section within the adult clinical pharmacology department

Since the program’s inception, more than 125 participants have graduated from the T32 training programs. An annual meeting provides an opportunity for fellows to meet other trainees in the program, learn about research at other institutions, and access presentations by experts in the field and fellow trainees.

California

University of California, San Diego

Victor Nizet, M.D.
Department of Pediatrics
San Diego, CA
Telephone: 858-534-7408
Email: vnizet@ucsd.edu

Adriana Tremoulet, M.D.
Department of Pediatrics
San Diego, CA
Telephone: 858-246-0012
Email: atremoulet@ucsd.edu

University of California, San Francisco

Leslie Floren, Pharm.D.
School of Pharmacy
San Francisco, CA
Telephone: 415-514-3559
Fax: 415-514-4365
Email: leslie.floren@ucsf.edu

Illinois

University of Chicago Medical Center

Peter O’Donnell, M.D.
Section of Hematology/Oncology
Chicago, IL
Telephone: 773-834-1634
Email: podonnel@bsd.uchicago.edu

Missouri

Children’s Mercy Hospitals and Clinics, Kansas City

Jonathan Wagner, D.O.
Division of Clinical Pharmacology, Toxicology, and Therapeutic Innovation
Kansas City, MO
Telephone: 816-731-7240
Email: jbwagner@cmh.edu

Jennifer Goldman, M.D.
Division of Clinical Pharmacology, Toxicology, and Therapeutic Innovation
Kansas City, MO
Telephone: 816-234-3061
Email: jlgoldman@cmh.edu

North Carolina

Duke University

Michael Cohen-Wolkowiez, M.D., Ph.D.
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
Department of Pediatrics
Durham, NC
Telephone: 919-668-8812
Email: michael.cohenwolkowiez@duke.edu

University of North Carolina at Chapel Hill

Kim L. R. Brouwer, Pharm.D., Ph.D.
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
Division of Pharmacotherapy and Experimental Therapeutics
UNC Eshelman School of Pharmacy
Chapel Hill, NC
Telephone: 919-962-7030
Email: kbrouwer@unc.edu

Ohio

Cincinnati Children’s Hospital Medical Center

Sonya Tang Girdwood, M.D., Ph.D.
Division of Clinical Pharmacology
Cincinnati, OH
Email: sonya.tanggirdwood@cchmc.org

Pennsylvania

Children’s Hospital of Philadelphia

Kevin Downes, M.D.
Jefferson-CHOP Collaborative Clinical Pharmacology Postdoctoral Training Program
Division of Infectious Diseases
Philadelphia, PA
Telephone: 215-590-4024
Email: downeskj@email.chop.edu

Thomas Jefferson University

Scott A. Waldman, M.D., Ph.D.
Jefferson-CHOP Collaborative Clinical Pharmacology Postdoctoral Training Program
Department of Biochemistry and Molecular Pharmacology
Philadelphia, PA
Telephone: 215-955-6086
Email: scott.waldman@jefferson.edu

Walter Kraft, M.D.
Jefferson-CHOP Collaborative Clinical Pharmacology Postdoctoral Training Program
Department of Pharmacology and Experimental Therapeutics
Philadelphia, PA
Telephone: 215-955-9077
Email: walter.kraft@jefferson.edu

top of pageBACK TO TOP